Clinical Dynamix
The Sr. Leader, Toxicology directs the strategic direction of the toxicology function, ensuring studies comply with regulatory standards and guiding safety pharmacology and toxicology strategies across discovery and development programs. This role provides oversight of protocol preparation, data interpretation, regulatory document contributions, and resource planning while representing preclinical development on cross‑functional teams.
Clinical Dynamix matches exceptional talent with cutting-edge companies focused in: Pharmaceutical, Biotechnology, Medical Device/Diagnostics & Gene Therapy
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinical Dynamix.
Clinical Dynamix didn’t post a salary, so this is our estimate from similar listings.
28% above the average for this role
Senior Vice President, Preclinical Toxicology
Nurix
Sr. Scientific Director, Toxicology
lifelancer
Scientific Director, Toxicology
Neurocrine Biosciences
Toxicology and Safety Pharmacology Study Coordinator
Neurocrine Biosciences
Senior Director, Toxicology
pharmaron
Director, Toxicology
Praxis Precision Medicines, Inc.